نتایج جستجو برای: chronic obstructive pulmonary diseases

تعداد نتایج: 1382253  

Journal: :BMC Pulmonary Medicine 2006
Don D Sin SF Paul Man Darcy D Marciniuk Gordon Ford Mark FitzGerald Eric Wong Ernest York Rajesh R Mainra Warren Ramesh Lyle S Melenka Eric Wilde Robert L Cowie Dave Williams Roxanne Rousseau

BACKGROUND Systemic inflammation is associated with various complications in chronic obstructive pulmonary disease including weight loss, cachexia, osteoporosis, cancer and cardiovascular diseases. Inhaled corticosteroids attenuate airway inflammation, reduce exacerbations, and improve mortality in chronic obstructive pulmonary disease. Whether inhaled corticosteroids by themselves or in combin...

2017
Paul Zarogoulidis Theodora Tsiouda Wolfgang Hohenforst-Schmidt Chrysa Sardeli Haidong Huang Lonny Yarmus Christoforos Kosmidis Konstantinos Porpodis Nikolaos Barbetakis Dimitrios Paliouras Lutz Freitag Yan-Gao Man

Lung diseases are very common among several patients such as; asthma, chronic obstructive pulmonary disease, lung cancer, cystic fibrosis and pulmonary fibrosis. In many of these diseases we already have inhalation therapies, however; for others we have only systematic administration. There are also diseases of the lung that cause pulmonary hypertension and architectural damage to the lung such...

2013
Marina Rodrigues Bueno Macri Jair Mendes Marques Rosane Sampaio Santos Ana Maria Furkim Irinei Melek Daniel Rispoli Maria Cristina de Alencar Nunes

INTRODUCTION  Chronic obstructive pulmonary disease is characterized by progressive and partially reversible obstruction of pulmonary airflow. AIM  To characterize swallowing in patients with chronic obstructive pulmonary disease and correlate the findings with the degree chronic obstructive pulmonary disease, heart and respiratory rate, oxygen saturation, and smoking. METHOD  We conducted ...

2012

Keywords Chronic obstructive pulmonary disease (COPD), airflow obstruction, relief of symptoms, maintenance treatment, exacerbations. 1 correction related to a change on p. 4 Guideline on clinical investigation of medicinal products in the treatment of chronic obstructive pulmonary disease (COPD) EMA/CHMP/700491/2012 2/17 Guideline on clinical investigation of medicinal products in the treatmen...

2013
Adam KH Usher Robert A Stockley

BACKGROUND The possible relationship between chronic inflammatory diseases and their co-morbidities has become an increasing focus of research. Both chronic periodontitis and chronic obstructive pulmonary disease are neutrophilic, inflammatory conditions characterized by the loss of local connective tissue. Evidence suggests an association and perhaps a causal link between the two diseases. How...

Journal: :International Journal of Chronic Obstructive Pulmonary Disease 2020

Journal: :The European respiratory journal 2014
Jesús Díez-Manglano José Barquero-Romero Pedro Almagro Mena Jesús Recio-Iglesias Javier Cabrera-Aguilar Francisco López-García Ramón Boixeda Viu Joan B Soriano

References 1 Vestbo J, Hurd SS, Agustı́ AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347–365. 2 Walters JA, Gibson PG, Wood-Baker R, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009; 1: ...

Journal: :Respiratory Research 2006
Srirupa Mukhopadhyay John R Hoidal Tapan K Mukherjee

Tumor necrosis factor alpha (TNFalpha) is the most widely studied pleiotropic cytokine of the TNF superfamily. In pathophysiological conditions, generation of TNFalpha at high levels leads to the development of inflammatory responses that are hallmarks of many diseases. Of the various pulmonary diseases, TNFalpha is implicated in asthma, chronic bronchitis (CB), chronic obstructive pulmonary di...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید